# A Study of Itraconazole in the Management of Superficial Fungal Infections in India

> **NCT03923010** · PHASE4 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 40 (actual)

## Conditions studied

- Mycoses

## Interventions

- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT03923010
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-06
- **Primary completion:** 2020-03-25
- **Final completion:** 2020-03-27
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Further recruitment not possible due to COVID 19 impact. Hence a decision to close study was taken by the sponsor in Aug 2020
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03923010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03923010, "A Study of Itraconazole in the Management of Superficial Fungal Infections in India". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03923010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*